Cardiovascular morbidity in a randomized trial comparing GnRH-agonist and GnRH-antagonist among patients with advanced prostate-cancer and pre-existing cardiovascular disease.
auajournals.org/doi/10.1097...
Less CV complications in patients treated with antagonists.
Is my understanding of terminology correct that these results favor degaralix (firmanon) over Lupron (Eligard)?
I would like to know how casodex scores in this context.
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic PC. The EXTEND Phase 2 Randomized Clinical Trial(off topic) Firmagon useful for treating pedophilia
A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgenOral Relumina better that leuprolide in HERO trial 
What Would You Advise Please?
